Jacob Gottlieb is an entrepreneur who is responsible for creating several businesses throughout his career. Gottlieb created Altium Capital in June of 2018. Altium Capital is an investment fund who focuses on growing companies that works in the healthcare industry. Altium Capital works out of New York City to find the growing companies who are making advances in medical treatments. Gottlieb was able to use Altium Capital to make its’ first investment in Oramed Pharmaceuticals (ORMP). Oramed was appealing to Altium Capital because Oramed was working on an alternative treatment for diabetes that could be taken orally. Before there was an Altium Capital, the year was 2005 when Gottlieb created a hedge fund called Visium Asset Management. The hedge fund would grow to $8 billion.
Gottlieb earned a degree in Economics from Brown University and he studied medicine at New York University Medical School. There are other credentials held by Gottlieb such as becoming a Chartered Financial Analyst (CFA) in 2001. His expertise has led him Altium Capital to make a 9.81 percent investment stake in a company called Sellas Life Sciences. Sellas Life Sciences are making advances in cancer immunotherapy that will help find cancer. It got the attention of many investors with the use of drugs that help fight triple negative breast cancer. The triple negative breast cancer is considered to be very aggressive and can spread rapidly. Altium Capital also made an investment in companies such as Amarin and Orgenics, Ltd.
Gottlieb is an entrepreneur, but he is also a philanthropist. As a philanthropist, Gottlieb focus on the education of the youth. He has been responsible for raising millions of dollars for philanthropic projects that involved the East Harlem Tutorial Program, New Yorkers for Children, and several other organizations. Gottlieb also contributed time to help non-profit organizations.